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Teaching a new dog old tricks?
Dale B Wigley
The recently determined crystal structures of fragments of
the human and vaccinia virus type IB topoisomerases
reveal unexpected similarity with the lambda family of site-
specific recombinases. The conservation of structure
suggests a common mechanism, indicating that
topoisomerase activity may be the consequence of
uncoupling DNA strand cleavage/religation from synapsis.
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It is understandable why the maintenance of the genome
should be of prime concern to an organism, and it is not
surprising to discover that there are a wide variety of
proteins associated with that task. Topoisomerases are
one such group of enzymes which are responsible for
catalysing a number of complicated interconversions of
different topological states of DNA, including alteration
of supercoiling and chromosome decatenation. Site-
specific recombinases are equally important for a differ-
ent set of complex reactions that are responsible for
events as apparently diverse as chromosome segregation
and genetic transposition. For a comparison of the overall
reactions of type I topoisomerases and site-specific
recombinases see Figure 1. Intriguingly, although both
classes of enzyme catalyse a wide range of reactions, they
have been shown to share a number of mechanistic simi-
larities, most notably a magnesium ion independent reac-
tion and the formation of a covalent 3′-phosphotyrosine
enzyme–DNA intermediate.
There are two families of type I topoisomerases, desig-
nated IA and IB [1]. The crystal structure of a type IA
topoisomerase from Escherichia coli was reported several
years ago [2]. The structure revealed a large cavity within
the protein that was proposed to accommodate a DNA
duplex as part of the so-called ‘strand-passage’ mecha-
nism. This mechanism involves passage of a DNA duplex
through a gateway formed by cleavage of a separate
single-stranded region of DNA. A strand-passage mecha-
nism is also proposed for the type II topoisomerases
(reviewed in [3]). Recent crystal structures of fragments
of human topoisomerase IB [4,5] and the catalytic domain
of vaccinia virus topoisomerase [6] have revealed fas-
cinating glimpses of the catalytic mechanism of these
enzymes. The structure of the human topoisomerase has
been determined in two complexes with DNA: one is of
the initial protein–DNA complex, whereas the other is of
an intermediate on the reaction pathway in which the
enzyme has cleaved the DNA and formed a 3′-phospho-
tyrosine covalent linkage at the nick site. The vaccinia
topoisomerase structure is that of the free protein and,
as expected, shows structural homology with a compara-
ble region of the human enzyme that contains the active
site and with which it shares considerable amino acid
sequence homology. The overall shape of the human
enzyme reveals a large central cavity reminiscent of the
type IA topoisomerase structure. The folds of the IA and
IB topoisomerases, however, are completely different.
From a biochemical perspective there are also significant
differences in the mechanism between the IA and IB
enzymes, including the requirement for magnesium ions
by IA topoisomerases and a difference in the nature of the
phosphotyrosine intermediate in IA and IB enzymes (5′
or 3′, respectively). For these and other reasons, a differ-
ent mechanism is proposed for the IB topoisomerases [5]
(Figure 2). This ‘controlled rotation’ mechanism is very
different from the strand-passage mechanism proposed
for other topoisomerases.
A quite unexpected discovery was that the human and
vaccina topoisomerases share structural homology with a
family of site-specific recombinases for which four inde-
pendent structures were determined last year (reviewed
in [7]) (Figure 3). What is the biochemical significance
of this similarity? Hints about a link between type IB
topoisomerases and recombinases have been accruing in
the literature for a number of years. Experimental data
showing that the vaccinia topoisomerase was able to
catalyse the resolution of Holliday junctions and that it
was unique amongst topoisomerases in having a strict
site selectivity were important clues about this linkage.
The observation that by uncoupling the recombinases
from recombination per se, it was possible to observe
topoisomerase activity, albeit rather poor, was also impor-
tant. However, hindsight is a wonderful thing and the
extent of the underlying connection has only become
apparent since the determination of the crystal structures
of these enzymes. It is now evident that, despite a com-
plete lack of detectable sequence homology, the two
enzyme families promote catalysis by a similar mechanism
based upon a conserved catalytic framework (Figure 4).
Consequently, the biochemical outcome of the reaction
appears to result from a subtle control of catalysis rather
than by an altered chemical mechanism. If that is indeed
the case, what might be the structural and chemical bases
for this control mechanism?
Recombinases carry out a highly controlled cleavage/reli-
gation reaction that is tightly coupled to the association
of two DNA duplexes prior to strand exchange (referred
to as synapsis). Topoisomerase activity, on the other
hand, can be regarded as the consequence of uncoupling
strand exchange from cleavage and rejoining. The obvious
explanation for this is that it is the association of protein
monomers at synapsis that controls the nuclease and/or
religation activity of the recombinases (i.e. that the acti-
vation requires cooperativity between partner protein
molecules). The biochemical evidence is clear on this
point, recombinases can bind to their target sequences
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Figure 1
Reactions catalysed by type IB
topoisomerases and site-specific
recombinases. (a) In type IB topoisomerases
the enzyme (represented by a blue circle)
cleaves a single strand of the duplex and
forms a covalent linkage with the DNA
(denoted by a dot). The DNA is then relaxed
before the DNA is rejoined. (b) In site-specific
recombinases the reaction involves two pairs
of enzyme molecules and two separate
duplexes. One enzyme molecule in each pair
cleaves the DNA and forms a covalent linkage
(again denoted by a dot). The free 5′-end at
each cleavage site is then swapped with its
equivalent in the partner duplex, before
rejoining of the DNA takes place. This cross-
shaped DNA product is known as a Holliday
junction. The final two steps of the reaction
are equivalent to the first two except that it is
the other enzyme molecule in each pair that
performs the cleavage and religation.
Structure
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but will not cleave the DNA in the absence of their part-
ners. By contrast, the topoisomerases appear to operate
as monomers. Hints for how this ‘activation’ process
might occur are provided by the variety of structures that
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Figure 2
The proposed ‘controlled rotation’ mechanism
for topoisomerase IB. The reaction is initiated
by cleavage of a single strand of the duplex
DNA as it resides within the central cavity of
the enzyme (a–c). The duplex is then allowed
to rotate within this central cavity (d) before
rejoining of the cleaved strand (e,f) and
release of the relaxed DNA (g). Each rotation
of the DNA duplex at (d) results in the
relaxation of one supercoil. (The figure was
reproduced from [5] with permission.)
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Figure 3
Stereoview superposition of the crystal
structures of human topoisomerase IB (red
and green) and HP1 recombinase (grey) in
the region of the active sites. The folds of the
catalytic domains of the two enzymes are
remarkably similar. (The figure was
reproduced from [4] with permission.)
are now available. One of the recombinase structures,
XerD [8], shows that the active-site tyrosine is positioned
away from the other active-site residues. This observa-
tion led to a proposal for activation in which a conforma-
tional change moves the active-site tyrosine from being
buried in the protein interior, to place it in position in
the active site. Evidence that this conformational change
is a result of protein contacts is provided by the structure
of another recombinase family member, HP1 integrase [9],
which crystallises as a dimer and in which the conforma-
tion of the tyrosine is in the activated position, even in
the absence of DNA (Figure 5). The structure of Cre
recombinase bound to a pseudo Holliday junction shows
the tyrosine to be in the activated position both before and
after cleavage of the DNA [10]. Intriguingly, this activa-
tion process appears to be mirrored in the topoisomerases.
The structure of the vaccinia topoisomerase corresponds
to the inactive conformation, while the human enzyme is
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Figure 4
The chemical mechanism of type IB topoisomerases and lambda family
site-specific recombinases. The reaction can be considered in four
stages (a–d) with two pentavalent phosphorous transition states (b and
d). The reaction begins with the initial protein–DNA complex (a) and
proceeds via the transition state (b) to the stable 3′-phosphotyrosine
DNA–enzyme intermediate (c). The reaction is completed by the attack
of a 5′-hydroxyl from the same duplex (in the case of topoisomerases) or
from a different duplex (recombinases), via a similar transition state (d) to
give the products (a). DNA strand swapping (recombinases) or
‘controlled rotation’ (topoisomerases) occurs after formation of the
phosphotyrosine adduct. The base shown in the scheme is always a
histidine in recombinases, but the equivalent residue is a lysine in
topoisomerases. In addition, the histidine residue shown is exceptionally
a tryptophan in Cre recombinase. This means that although proton
transfers are shown to be taking place at certain stages in the reaction
pathway, these transfers may not be complete but might be more akin to
hydrogen bonds between the enzyme and the substrates that would
serve either to stabilise or activate intermediates of the catalytic pathway. 
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in the activated conformation in both the pre- and post-
cleavage DNA complexes. As all of the topoisomerase
structures are monomeric, however, this suggests that acti-
vation is a consequence of binding to DNA rather than to
a protein partner. Thus topoisomerase activity is uncou-
pled from the formation of protein–protein contacts (i.e.
synapsis). The structures of the free human topoisomerase
IB or of the vaccinia enzyme bound to DNA should be
revealing with regard to this activation process.
Recent biochemical data have uncovered some interest-
ing alternative catalytic activities of these recombinases
and topoisomerases. It has been shown that both the vac-
cinia topoisomerase [11] and Flp recombinase [12] are
able to act as ribonucleases on substrates in which the
base next to the normal cleavage site is a ribonucleotide
rather than the usual deoxyribonucleotide. The reaction
proceeds by the usual chemistry until step (c) in the
scheme shown in Figure 4. However, it is the 2′-hydroxyl
of the ribose sugar moiety of the covalent enzyme–DNA
adduct, rather than the 5′-hydroxyl of the cleaved DNA,
that attacks the phosphotyrosine. This attack results in
the formation of a cyclic 2′,3′-ribose phosphate on the
3′-side of the cleavage site and the normal 5′-hydroxyl on
the other side. Thus the enzyme is now acting as a nucle-
ase. As if this were not enough, it has also been shown
that the vaccinia topoisomerase can take this reaction a
step further by ligating the 2′,3′-cyclic phosphate to the
5′-hydroxyl of the DNA [13], by means of a mechanism
that does not require the active-site tyrosine (shown by
mutation to a phenylalanine). Thus the catalytic mecha-
nism of the active site itself can be uncoupled, by using
the appropriate substrates, to reveal an underlying cat-
alytic activity which is even simpler than that usually
observed with the ‘natural’ substrates.
These data allow us the fun of speculating about the
molecular evolution of this system. One can envisage a
protein capable of binding two RNA fragments and a
simple active site that promoted ligation of the fragments,
perhaps itself evolving from a primordial RNase. This
system could have developed further to replace the
attacking 2′-hydroxyl of the RNA with that from a tyrosine
sidechain in the protein. This active site would then be
capable of elementary breakage and reunion activity upon
DNA. Later adaptation could produce a topoisomerase by
taking a tight grip on the DNA duplex at least on one side
of the single-strand nick. Recombination would then
evolve by making a tight grip on both sides of the nick site
and then coordinating the swapping of strands between
partner proteins in a recombination synapse. Whatever the
evolutionary pathway may have been, we are fortunate to
have such marvellous insights into the mechanism of
these enzymes from the mounting structural and biochem-
ical evidence. Nevertheless, although these catalytic ‘snap-
shots’ are a fascinating preview, we are still some way from
seeing the entire movie. Let us hope that further struc-
tures will help to explain the plot.
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